Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
Sheena Jonathan	Director	2026-07-13	9K shares	$2.52M
TINKERBELLE II TR U/A DTD 10/22/2021	Officer, Director	2026-07-06	1K shares	$280K
SOLOMON MOSHKEVICH	Officer	2026-07-01	3K shares	$819K
DANIEL RABINOWITZ	Officer	2026-07-01	17K shares	$4.56M
ROSENMAN HERM	Director	2026-06-24	17K shares	$4.13M
RABINOWITZ DANIEL	Officer	2026-06-24	34K shares	$7.89M
Chapman Rowan E	Director	2026-06-16	3K shares	$643K
Rabinowitz Matthew	Director, Officer	2026-06-12	100K shares	$21.92M
Marcus Gail Boxer	Director	2026-06-05	11K shares	$2.39M
Chapman Steven Leonard	Officer, Director	2026-06-04	41K shares	$9.09M

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-06

2026-07-06

Natera announced that Monica Bertagnolli resigned from the board of directors on July 1, 2026, effective immediately, because of her new position at the National Academy of Medicine. The company stated that her resignation was not due to any disagreement with Natera's operations, policies, or practices.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding NATERA INC (NTRA)?

Major stakeholders currently include Jpmorgan Chase & Co ($2.5B), Price T Rowe Associates INC /md/ ($2.4B), BlackRock, Inc. ($2.1B). Based on the latest 13F filings, there are a total of 759 tracked investment funds and institutions maintaining positions in NTRA.

What is the overall institutional sentiment toward NTRA recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $3.7B, driven by 381 managers accumulating shares while 371 reduced their exposure.

Which institutions have been selling or reducing their NTRA positions?

In the latest period, 266 funds trimmed their holdings, and 105 managers completely exited their positions. The aggregate reported sell value was $12.5B.

Are there any notable investors adding NTRA to their portfolios?

Yes, buying activity remains notable. 81 institutions opened new positions in {ticker}, and 300 existing holders added to their shares. The total reported buy value for the quarter amounted to $14.6B.